Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 8.89% | $80.94M | £210.71B | 35.34% | 76 Outperform | |
| HSBC Holdings | 8.03% | $73.11M | £187.79B | 45.80% | 79 Outperform | |
| Shell (UK) | 7.24% | $65.96M | £164.04B | 9.52% | 77 Outperform | |
| Unilever | 4.72% | $42.94M | £109.50B | -1.89% | 77 Outperform | |
| Rolls-Royce Holdings | 3.98% | $36.26M | £92.02B | 110.88% | 71 Outperform | |
| British American Tobacco | 3.62% | $32.92M | £90.49B | 42.05% | 60 Neutral | |
| BP p.l.c. | 3.20% | $29.10M | £71.08B | 19.79% | 63 Neutral | |
| GlaxoSmithKline | 3.16% | $28.78M | £72.30B | 37.09% | 82 Outperform | |
| National Grid | 2.54% | $23.10M | £58.45B | 18.65% | 76 Outperform | |
| Barclays | 2.47% | $22.46M | £57.15B | 56.26% | 76 Outperform |